Apamargadi nasya in Ardhavbhedak

Randomised open control clinical trial to evaluate the efficacy of Apamargadi Nasya in Ardhavbhedak with special reference to Migraine

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/041262

Enrollment

Registered

2022-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient showing classical symptoms of ardhavbhedaka like Bhed , tod sadrush vedana , ardhamastak vedana etc appears in interval of 10 to 15 days. 2.Patent irrespective of gender,religion,socio economic status. 3.Willing to give inform consent and able to participate in study.

Exclusion criteria

Exclusion criteria: 1. Pregnant women 2. People above age of 50yrs 3. Patient not fit for nasya which told to be anarh for Nasya.

Design outcomes

Primary

Measure	Time frame
1] TO ASSESS THE SAFETY MEASURES OF APAMARGADI NASYA IN MANAGEMENT OF ARDHAVABHEDAKA 2] TO STUDY MIGRAINE LITERATURE IN DETAILS 3] TO STUDY ARDHAVABHEDAKA LITERATURE IN DETAILS. 4] TO PROPOSE ANCIENT MODALITIES OF TREATMENT IN ARDHAVABHEDAKA. Timepoint: 0 TO 15 DAYS	—

Secondary

Measure	Time frame
Pain with VAS [ VISUAL ANALOG SCALE] VAS score 0 mm : none VAS score 1mm- 20 mm : Annoying VAS score 20mm-40mm: uncomfortable VAS score 40mm-60mm:Dreadful Vas score 80mm- 100mm : agonizingTimepoint: 0-30 days	—

Countries

India

Contacts

Public ContactDR Ravikumar patil

YASHWANT AYURVEDIC COLLEGE KODOLI

yaminigawand2395@gmail.com8369193855

Outcome results